Join to View Full Profile
450 Brookline AveBoston, MA 02215
Phone+1 617-632-3468
Dr. Kehl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2014 - 2017
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2008 - 2011
Northwestern University The Feinberg School of MedicineClass of 2008
Certifications & Licensure
MA State Medical License 2012 - 2026
NH State Medical License 2024 - 2024
TX State Medical License 2014 - 2019
IL State Medical License 2010 - 2014
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Empirical evaluation of artificial intelligence distillation techniques for ascertaining cancer outcomes from electronic health records.Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, Noman Ashraf, Gordon J Harris, Kenneth L Kehl
NPJ Digital Medicine. 2025-06-10 - 3 citationsClinical Trial Notifications Triggered by Artificial Intelligence-Detected Cancer Progression: A Randomized Trial.Tali Mazor, Karim S Farhat, Pavel Trukhanov, James Lindsay, Matthew Galvin
JAMA Network Open. 2025-04-01 - 1 citationsCollaborative large language models for automated data extraction in living systematic reviews.Muhammad Ali Khan, Umair Ayub, Syed Arsalan Ahmed Naqvi, Kaneez Zahra Rubab Khakwani, Zaryab Bin Riaz Sipra
Journal of the American Medical Informatics Association. 2025-04-01
Press Mentions
Researchers Showcase How AACR Project GENIE Is Powering New Insights into Cancer CareJune 18th, 2025- Daily Takeaways from the AACR Annual Meeting 2025: Monday, April 28April 28th, 2025
- Computer Platform Helps Match Patients with Cancer to Trials of Targeted TherapyOctober 12th, 2022
- Join now to see all
Grant Support
- Deep clinical trajectory modeling to optimize accrual to cancer clinical trialsDANA-FARBER CANCER INST2020–2025
- Deep clinical trajectory modeling to optimize accrual to cancer clinical trialsDANA-FARBER CANCER INST2020–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
